BioLineRx Initiates Phase 2 Trial for BL-8040 as Novel Stem Cell Mobilization Treatment – Investing News Network (press release) (registration) (blog)
|
BioLineRx Initiates Phase 2 Trial for BL-8040 as Novel Stem Cell Mobilization Treatment
Investing News Network (press release) (registration) (blog) BioLineRx Ltd. (NASDAQ:BLRX) announced the initiation of a Phase 2 trial for BL-8040 as a novel approach for the mobilization and collection of bone marrow stem cells from the peripheral blood circulation. According to the news: The Phase 2 open-label … BioLineRx initiates mid-stage study of BL-8040 as stem cell mobilization agent BioLineRx Initiates Phase 2 Trial of BL-8040 For Mobilization and Collection of Bone Marrow Stem Cells (NASDAQ … |
